Waka Ishida Selected Research

Waka Ishida Research Topics

Disease

22	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 04/2022 - 01/2004
7	Inflammation (Inflammations) 01/2022 - 02/2011
6	Conjunctivitis 11/2021 - 10/2003
4	Hypersensitivity (Allergy) 04/2022 - 02/2005
3	Endophthalmitis (Ophthalmia) 01/2022 - 11/2019
3	Infections 01/2022 - 01/2016
3	Keratitis 08/2017 - 01/2012
3	Bacterial Infections (Bacterial Infection) 08/2017 - 12/2014
2	Glaucoma 01/2022 - 01/2019
2	Corneal Injuries 01/2022 - 08/2017
2	Necrosis 12/2014 - 07/2013
2	Dry Eye Syndromes (Dry Eye Syndrome) 12/2014 - 07/2013
2	Uveitis 07/2014 - 01/2005
2	Eosinophilia 08/2013 - 04/2011
1	Fibrosis (Cirrhosis) 01/2022
1	Cicatrix (Scar) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Retinal Detachment (Retinal Detachments) 11/2019
1	Atopic Dermatitis (Atopic Eczema) 07/2019
1	Hyperemia 01/2019
1	Ocular Hypertension (Glaucoma, Suspect) 01/2019
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2019
1	Rhinitis 11/2018
1	Psoriatic Arthritis 10/2018
1	Immediate Hypersensitivity 07/2013
1	Chronic Urticaria 01/2012
1	Atrophy 01/2012
1	Heart Failure 01/2012
1	Alopecia (Baldness) 01/2011
1	Contact Dermatitis (Eczema, Contact) 01/2011
1	Allergic Contact Dermatitis 01/2011
1	Asthma (Bronchial Asthma) 01/2008

Drug/Important Bio-Agent (IBA)

9	AntigensIBA 04/2022 - 10/2003
9	CytokinesIBA 12/2017 - 02/2005
6	Ophthalmic Solutions (Eye Drops)IBA 04/2022 - 05/2006
4	AllergensIBA 11/2021 - 04/2005
3	Retinaldehyde (Retinal)IBA 01/2022 - 02/2011
3	VaccinesIBA 11/2021 - 05/2015
3	Therapeutic UsesIBA 11/2021 - 01/2012
3	InterleukinsIBA 08/2015 - 02/2005
2	OvalbuminIBA 04/2022 - 11/2014
2	AlarminsIBA 01/2022 - 08/2013
2	Peroxidase (Myeloperoxidase)IBA 01/2022 - 11/2019
2	Vancomycin FDA LinkGeneric 01/2021 - 11/2019
2	Interleukin-33IBA 12/2017 - 08/2015
2	LipopolysaccharidesIBA 08/2017 - 01/2016
2	Peptides (Polypeptides)IBA 01/2016 - 07/2014
2	rebamipideIBA 12/2014 - 07/2013
2	SecretagoguesIBA 12/2014 - 07/2013
2	Pharmaceutical PreparationsIBA 12/2014 - 07/2013
2	Messenger RNA (mRNA)IBA 12/2014 - 07/2014
2	MucinsIBA 12/2014 - 07/2013
2	HCEIBA 08/2013 - 07/2013
2	aluminum sulfate (alum)IBA 04/2011 - 08/2008
2	LigandsIBA 12/2008 - 08/2008
1	Fluorescein (Funduscein)FDA LinkGeneric 04/2022
1	Evans Blue (Blue, Evans)FDA Link 04/2022
1	CollagenIBA 01/2022
1	dupilumabIBA 07/2019
1	PeriostinIBA 04/2019
1	K-115IBA 01/2019
1	rho-Associated KinasesIBA 01/2019
1	Protein Kinase InhibitorsIBA 01/2019
1	epinastine FDA Link 01/2019
1	Anti-Allergic Agents (Antiallergic Agents)IBA 11/2018
1	Histamine Antagonists (Antihistamines)IBA 11/2018
1	Mast Cell StabilizersIBA 11/2018
1	Infliximab (Remicade)FDA Link 10/2018
1	PapainIBA 12/2017
1	lipopolysaccharide-binding proteinIBA 08/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2017
1	Thymic Stromal LymphopoietinIBA 08/2015
1	Interleukin-8 (Interleukin 8)IBA 12/2014
1	interstitial retinol-binding proteinIBA 07/2014
1	Interleukin-1 (Interleukin 1)IBA 08/2013
1	Chemokine CCL11IBA 08/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2013
1	Phosphotransferases (Kinase)IBA 07/2013
1	Member 14 Tumor Necrosis Factor ReceptorsIBA 02/2012
1	Transcription Factors (Transcription Factor)IBA 01/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2012
1	Olopatadine Hydrochloride (Patanol)FDA Link 01/2012
1	Tuberculin (PPD)IBA 01/2011
1	4-phenylenediamine (p-phenylenediamine)FDA Link 01/2011
1	Hair DyesIBA 01/2011
1	staphylococcal enterotoxin BIBA 09/2010
1	alpha-galactosylceramideIBA 09/2008
1	Interleukin-17 (Interleukin 17)IBA 01/2008
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2006
1	Integrin alpha4beta1 (VLA-4)IBA 04/2006
1	ChemokinesIBA 04/2006
1	OX40 LigandIBA 02/2006

Therapy/Procedure

5	Immunotherapy 11/2021 - 11/2014
4	Oral Administration 11/2021 - 04/2013
2	Phage Therapy 01/2021 - 11/2019
1	Filtering Surgery 01/2022
1	Therapeutics 01/2021
1	Hydrophilic Contact Lenses (Hydrophilic Contact Lens) 01/2019
1	Contact Lenses 12/2017